The Clinical Laboratory Innovation Axcelerator™
CLIAx offers a “soft landing” to testing innovators from around the world and provides sales support for products and services addresses the markets of Early Detection, Personalized Medicine and Wellness and Prevention.
Helping Innovative Companies Introduce Laboratory Developed Tests (LDT’s) into the U.S. Market.
Everything Your Startup Needs to Axcelerate
#Meet the Hosts
20/20’s OneTest for the early detection of cancers (www. OneTestforCancer.com) has seen increasing adoption in each of the above sectors and would be marketed alongside the novel tests being run out of the CLIAx facility. The Accelerator will prioritize tests that aid in the prevention and early detection of major disease like cancer, heart disease, and diabetes.
20/20 GeneSystems, Inc., has a growing sales and marketing presence in the following U.S. diagnostics markets:
All within 5 miles of CLIAx
15810 Gaither Drive, Gaithersburg, Maryland